Benjamin Bergstrom, DVM, MS, DACVO, helps general practitioners distinguish between these two commonly confused conditions ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer ...

The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye ...

The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...

Advise neomycin-sensitive patients to avoid the ... Ciloxan® ophthalmic ointment and solution (cipro-floxacin), Vigamox® ophthalmic solution (moxifloxacin), Ocuflox® ophthalmic solution ...

Sodium Chloride Ophthalmic Solution, 5% Hypertonicity Eye Drops: 0363-0193-13; lots 19105 and 19050. Lubricant Eye Ointment PF Soothing: 0363-0191-50; lot TDB. Altaire is recalling 74 lots from ...

Over-the-counter ophthalmic products were voluntarily recalled due to a manufacturing deviation discovered during a U.S. Food and Drug Administration audit, a notice says. Pharmaceutical ...

The affected products include: Artificial Tears Ophthalmic Solution (NDC# 50268-043-15) Carboxymethylcellulose Sodium Ophthalmic Gel 1% (NDC# 50268-066-15) Carboxymethylcellulose Sodium Ophthalmic ...

to launch an authorized generic of Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension), which treats and relieves bacterial eye infections. Maxitrol® and ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic Solution ...